MYGN:NASDAQ
Myriad Genetics Inc
$3.89
arrow_downward
-6.04%(-0.25) 1D
Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
$4.15
High
$4.17
Low
$3.86
Mkt. cap
372.08M
Avg. vol.
1.85M
Volume
0.00
52-wk high
$8.59
52-wk low
$2.74
EPS
-$1.20
Beta
1.68
Shares outstanding
95.65M
No. of employees
3K
Open
$4.15
High
$4.17
Low
$3.86
Mkt. cap
372.08M
Avg. vol.
1.85M
Volume
0.00
52-wk high
$8.59
52-wk low
$2.74
EPS
-$1.20
Beta
1.68
Shares outstanding
95.65M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
15 hours ago
Myriad Genetics stock falls after guidance reset and weak Q2 figures
Yahoo Finance
·
3 days ago
Myriad Genetics (MYGN) Stock Fair Value Moves Lower After Analyst Cuts And Guidance Reset
CarePlus VietNam
·
4 days ago
MYGN Q2 2026 Earnings: EPS Miss of -$0.25 Lands Far Below Consensus Estimate - Earnings Power Value
CarePlus VietNam
·
2 months ago
Myriad Genetics Q1 2026 Earnings: EPS Misses Estimates, Stock Declines - EPS Guidance Update
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com